Accusynth Speciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 1.09 Cr
as on 17-12-2024
- Company Age 45 Year, 8 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 4.80 M
as on 17-12-2024
- Revenue -25.45%
(FY 2020)
- Profit -63.09%
(FY 2020)
- Ebitda -61.87%
(FY 2020)
- Net Worth 5.87%
(FY 2020)
- Total Assets 7.64%
(FY 2020)
About Accusynth Speciality Chemicals
The Corporate was formerly known as Accusynth Pharma Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.09 Cr.
The company has closed loans amounting to ₹4.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mahesh Doshi, Kersi Tangri, Karl Tangri, and One other member serve as directors at the Company.
- CIN/LLPIN
U17110MH1979PTC021185
- Company No.
021185
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 1979
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Accusynth Speciality Chemicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Doshi  | Director | 27-Jul-2006 | Current |
Kersi Tangri  | Director | 27-Jul-2006 | Current |
| Karl Tangri | Director | 30-Sep-2024 | Current |
| Niraj Doshi | Director | 30-Sep-2024 | Current |
Financial Performance and Corporate Structure Insights of Accusynth Speciality Chemicals.
Accusynth Speciality Chemicals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 25.45% decrease. The company also saw a substantial fall in profitability, with a 63.09% decrease in profit. The company's net worth moved up by a moderate rise of 5.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accusynth Speciality Chemicals?
In 2020, Accusynth Speciality Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hildose Pharmaspecialities LlpActive 4 years 10 monthsKersi Tangri and Karl Tangri are mutual person
Biesterfeld Hildose Speciality Chemicals Private LimitedActive 1 year 1 monthKersi Tangri and Karl Tangri are mutual person
Avesta Pharma Private LimitedActive 15 years 6 monthsMahesh Doshi and Kersi Tangri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India Creation Date: 14 Oct 1991 | ₹1.70 M | Satisfied |
Central Bank Of India Creation Date: 29 Jul 1986 | ₹2.10 M | Satisfied |
Central Bank Of India Creation Date: 29 Jul 1986 | ₹1.00 M | Satisfied |
How Many Employees Work at Accusynth Speciality Chemicals?
Accusynth Speciality Chemicals has a workforce of 42 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accusynth Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accusynth Speciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
